{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T09:14:00Z","timestamp":1742807640546,"version":"3.32.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jns.2024.123055","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T16:08:52Z","timestamp":1715702932000},"page":"123055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammation"],"prefix":"10.1016","volume":"461","author":[{"given":"Dejan","family":"Jakimovski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferhan","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murali","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kian","family":"Jalaleddini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ati","family":"Ghoreyshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Bergsland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Weinstock-Guttman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Zivadinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10130","key":"10.1016\/j.jns.2024.123055_bb0005","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jns.2024.123055_bb0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jns.2024.123055_bb0015","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/CPJ.0000000000001045","article-title":"Multiple sclerosis phenotypes as a continuum: the role of neurologic reserve","volume":"11","author":"Vollmer","year":"2021","journal-title":"Neurol. Clin. Pract."},{"issue":"8","key":"10.1016\/j.jns.2024.123055_bb0020","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/14737175.2020.1757435","article-title":"MRI biomarkers of disease progression and conversion to secondary-progressive multiple sclerosis","volume":"20","author":"Tavazzi","year":"2020","journal-title":"Expert. Rev. Neurother."},{"issue":"1","key":"10.1016\/j.jns.2024.123055_bb0025","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12974-019-1674-2","article-title":"Molecular biomarkers in multiple sclerosis","volume":"16","author":"Ziemssen","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.jns.2024.123055_bb0030","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/jon.12527","article-title":"Atrophied brain lesion volume: a new imaging biomarker in multiple sclerosis","volume":"28","author":"Dwyer","year":"2018","journal-title":"J. Neuroimaging"},{"issue":"2","key":"10.1016\/j.jns.2024.123055_bb0035","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1148\/radiol.2019190306","article-title":"Atrophied brain T2 lesion volume at MRI is associated with disability progression and conversion to secondary progressive multiple sclerosis","volume":"293","author":"Genovese","year":"2019","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.jns.2024.123055_bb0040","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s00415-019-09643-z","article-title":"A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis","volume":"267","author":"Tavazzi","year":"2020","journal-title":"J. Neurol."},{"issue":"Pt 10","key":"10.1016\/j.jns.2024.123055_bb0045","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1093\/brain\/aws189","article-title":"Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis","volume":"135","author":"Choi","year":"2012","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jns.2024.123055_bb0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/jamaneurol.2016.4237","article-title":"Use of magnetic resonance imaging to visualize leptomeningeal inflammation in patients with multiple sclerosis: a review","volume":"74","author":"Zurawski","year":"2017","journal-title":"JAMA Neurol."},{"issue":"14","key":"10.1016\/j.jns.2024.123055_bb0055","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1177\/1352458518814117","article-title":"Slowly expanding\/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions","volume":"25","author":"Elliott","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2024.123055_bb0060","doi-asserted-by":"crossref","DOI":"10.1177\/13524585231169466","article-title":"Paramagnetic rim lesions are associated with greater incidence of relapse and worse cognitive recovery following relapse","author":"Reeves","year":"2023","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.jns.2024.123055_bb0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1474-4422(13)70233-3","article-title":"Body fluid biomarkers in multiple sclerosis","volume":"13","author":"Comabella","year":"2014","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jns.2024.123055_bb0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2217\/nmt-2020-0058","article-title":"Disease biomarkers in multiple sclerosis: current serum neurofilament light chain perspectives","volume":"11","author":"Jakimovski","year":"2021","journal-title":"Neurodegener Dis. Manag."},{"issue":"10","key":"10.1016\/j.jns.2024.123055_bb0075","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1093\/brain\/awab241","article-title":"The potential of serum neurofilament as biomarker for multiple sclerosis","volume":"144","author":"Bittner","year":"2021","journal-title":"Brain"},{"issue":"13","key":"10.1016\/j.jns.2024.123055_bb0080","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1177\/1352458519881428","article-title":"Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: a longitudinal retrospective 5-year study","volume":"26","author":"Jakimovski","year":"2020","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.jns.2024.123055_bb0085","doi-asserted-by":"crossref","first-page":"fcad183","DOI":"10.1093\/braincomms\/fcad183","article-title":"Proteomics and relationship with axonal pathology in multiple sclerosis: 5-year diffusion tensor imaging study","volume":"5","author":"Jakimovski","year":"2023","journal-title":"Brain Communicat"},{"issue":"3","key":"10.1016\/j.jns.2024.123055_bb0090","doi-asserted-by":"crossref","first-page":"2200018","DOI":"10.1002\/prca.202200018","article-title":"Analytical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis","volume":"17","author":"Qureshi","year":"2023","journal-title":"PROTEOMICS \u2013 Clin. Applicat."},{"key":"10.1016\/j.jns.2024.123055_bb0095","article-title":"Clinical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis","volume":"109688","author":"Chitnis","year":"2023","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.jns.2024.123055_bb0100","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/acn3.51996","article-title":"Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis","volume":"11","author":"Jalaleddini","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"issue":"9","key":"10.1016\/j.jns.2024.123055_bb0105","doi-asserted-by":"crossref","first-page":"e911","DOI":"10.1212\/WNL.0000000000201608","article-title":"Association of Choroid Plexus Inflammation on MRI with clinical disability progression over 5 years in patients with multiple sclerosis","volume":"100","author":"Bergsland","year":"2023","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2024.123055_bb0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2024.123055_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102653","article-title":"Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis","volume":"47","author":"Hildesheim","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"15 Supplement","key":"10.1016\/j.jns.2024.123055_bb0120","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1212\/WNL.96.15_supplement.4379","article-title":"A deep learning-based approach for simultaneously segmenting T2 lesions and T1 hypointensities in multiple sclerosis regulatory clinical trials (4379)","volume":"96","author":"Bergsland","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2024.123055_bb0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/13524585211010082","article-title":"CSF chitinase 3-like 1 is associated with iron rims in patients with a first demyelinating event","volume":"28","author":"Comabella","year":"2022","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.jns.2024.123055_bb0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00401-016-1636-z","article-title":"Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging","volume":"133","author":"Dal-Bianco","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.jns.2024.123055_bb0135","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00401-012-0992-6","article-title":"Astrocytes acquire morphological and functional characteristics of ependymal cells following disruption of ependyma in hydrocephalus","volume":"124","author":"Roales-Buj\u00e1n","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.jns.2024.123055_bb0140","doi-asserted-by":"crossref","first-page":"10923","DOI":"10.1038\/s41598-020-67934-2","article-title":"Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity","volume":"10","author":"Ayrignac","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jns.2024.123055_bb0145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/ene.15588","article-title":"Serum neurofilament-light and glial fibrillary acidic protein levels in hydroxychloroquine-treated primary progressive multiple sclerosis","volume":"30","author":"Camara-Lemarroy","year":"2023","journal-title":"Eur. J. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2024.123055_bb0150","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1084\/jem.20122192","article-title":"CNS myelin induces regulatory functions of DC-SIGN-expressing, antigen-presenting cells via cognate interaction with MOG","volume":"211","author":"Garcia-Vallejo","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jns.2024.123055_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.756264","article-title":"Expression of FLRT2 in postnatal central nervous system development and after spinal cord injury","volume":"14","author":"Li","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jns.2024.123055_bb0160","doi-asserted-by":"crossref","first-page":"827738","DOI":"10.3389\/fimmu.2022.827738","article-title":"High levels of cerebrospinal fluid kappa free light chains relate to IgM intrathecal synthesis and might have prognostic implications in relapsing multiple sclerosis","volume":"13","author":"Castillo-Villalba","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jns.2024.123055_bb0165","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/13524585221122210","article-title":"Leptomeningeal enhancement under different MS immunotherapies: a monocentric retrospective cohort study of 214 patients","volume":"29","author":"Friedli","year":"2023","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2024.123055_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104094","article-title":"Effect of ocrelizumab on leptomeningeal inflammation and humoral response to Epstein-Barr virus in multiple sclerosis. A pilot study","volume":"67","author":"Zivadinov","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.jns.2024.123055_bb0175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/1352458519892186","article-title":"Controversial association between leptomeningeal enhancement and demyelinated cortical lesions in multiple sclerosis","volume":"26","author":"Absinta","year":"2020","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.jns.2024.123055_bb0180","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/acn3.51060","article-title":"Temporal association of sNfL and gad-enhancing lesions in multiple sclerosis","volume":"7","author":"Rosso","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2024.123055_bb0185","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1212\/WNL.0000000000013016","article-title":"Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome","volume":"98","author":"Filippi","year":"2022","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2024.123055_bb0190","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221425","article-title":"Multicenter evaluation of AI-generated DIR and PSIR for cortical and Juxtacortical multiple sclerosis lesion detection","volume":"307","author":"Bouman","year":"2023","journal-title":"Radiology"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24001904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24001904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:30:47Z","timestamp":1736184647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X24001904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":38,"alternative-id":["S0022510X24001904"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2024.123055","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammation","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2024.123055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123055"}}